|
25/10/2022
|
07:00
|
Change of name to hVIVO plc effective
|
RNS
|
|
20/10/2022
|
07:00
|
Capital Markets Day
|
RNS
|
|
18/10/2022
|
07:00
|
CFO appointment & change of Board roles
|
RNS
|
|
30/09/2022
|
07:00
|
Positive in vitro results for FLU-v published
|
RNS
|
|
29/09/2022
|
09:30
|
Director dealings
|
RNS
|
|
27/09/2022
|
07:00
|
Upcoming Scientific Presentations
|
RNS
|
|
15/09/2022
|
07:00
|
Comment regarding press speculation
|
RNS
|
|
08/09/2022
|
07:01
|
Interim results and trading update
|
RNS
|
|
08/09/2022
|
07:00
|
Intention to change name to hVIVO plc
|
RNS
|
|
01/09/2022
|
07:20
|
CAP accreditation
|
RNS
|
|
25/08/2022
|
07:00
|
Notice of results
|
RNS
|
|
22/08/2022
|
07:00
|
£10.4m contract with existing Big Pharma client
|
RNS
|
|
04/08/2022
|
07:00
|
£6.2m Influenza human challenge study contract
|
RNS
|
|
05/07/2022
|
13:17
|
Result of AGM
|
RNS
|
|
30/06/2022
|
07:00
|
Omicron human challenge model
|
RNS
|
|
14/06/2022
|
07:00
|
£7.2m RSV human challenge study contract
|
RNS
|
|
10/06/2022
|
12:13
|
Board appointment amendment
|
RNS
|
|
10/06/2022
|
12:00
|
Annual Report and Notice of AGM
|
RNS
|
|
08/06/2022
|
07:00
|
Board appointment
|
RNS
|
|
07/06/2022
|
09:05
|
Second Price Monitoring Extn
|
RNS
|
|
07/06/2022
|
09:00
|
Price Monitoring Extension
|
RNS
|
|
07/06/2022
|
07:00
|
Final results
|
RNS
|
|
01/06/2022
|
07:00
|
GBP14.7m influenza contract signed
|
RNS
|
|
26/05/2022
|
07:00
|
Completion of Nominated Adviser due diligence
|
RNS
|
|
24/05/2022
|
07:00
|
Notice of results
|
RNS
|
|
18/05/2022
|
07:00
|
£7.3m Influenza human challenge study contract win
|
RNS
|
|
12/05/2022
|
07:00
|
Wellcome publication
|
RNS
|
|
05/05/2022
|
07:00
|
Vaccine field study contract
|
RNS
|
|
04/05/2022
|
07:00
|
Challenge virus manufacturing contract
|
RNS
|
|
04/05/2022
|
07:00
|
Comment re: speculation
|
RNS
|
|
28/04/2022
|
07:00
|
Appointment of Nominated Adviser and Joint Broker
|
RNS
|
|
13/04/2022
|
07:00
|
Proposal to Distribution in Specie Shareholders
|
RNS
|
|
12/04/2022
|
12:00
|
Presentation at World Vaccine Congress
|
RNS
|
|
06/04/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
06/04/2022
|
14:05
|
Second Price Monitoring Extn
|
RNS
|
|
06/04/2022
|
14:01
|
Price Monitoring Extension
|
RNS
|
|
06/04/2022
|
11:05
|
Second Price Monitoring Extn
|
RNS
|
|
06/04/2022
|
11:00
|
Price Monitoring Extension
|
RNS
|
|
31/03/2022
|
10:05
|
Characterisation Study results in Nature Medicine
|
RNS
|
|
25/03/2022
|
07:00
|
£5m RSV human challenge study contract win
|
RNS
|
|
09/03/2022
|
16:41
|
Second Price Monitoring Extn
|
RNS
|
|
09/03/2022
|
16:37
|
Price Monitoring Extension
|
RNS
|
|
08/03/2022
|
07:00
|
Trading Update and screening facilities expansion
|
RNS
|
|
07/03/2022
|
14:06
|
Second Price Monitoring Extn
|
RNS
|
|
07/03/2022
|
14:00
|
Price Monitoring Extension
|
RNS
|
|
07/03/2022
|
11:06
|
Second Price Monitoring Extn
|
RNS
|
|
07/03/2022
|
11:00
|
Price Monitoring Extension
|
RNS
|
|
02/03/2022
|
07:00
|
Investor Presentations
|
RNS
|
|
24/02/2022
|
07:00
|
CEO Appointment
|
RNS
|
|
22/02/2022
|
07:00
|
FDA Breakthrough Designation for Big Pharma RSV
|
RNS
|